Download
s12974-021-02316-7.pdf 4,21MB
WeightNameValue
1000 Titel
  • Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
1000 Autor/in
  1. Piepke, Marius |
  2. Clausen, Bettina H. |
  3. Ludewig, Peter |
  4. Vienhues, Jonas H. |
  5. Bedke, Tanja |
  6. Javidi, Ehsan |
  7. Rissiek, Björn |
  8. Jank, Larissa |
  9. Brockmann, Leonie |
  10. Sandrock, Inga |
  11. Degenhardt, Karoline |
  12. Jander, Alina |
  13. Roth, Vanessa |
  14. Schädlich, Ines S. |
  15. Prinz, Immo |
  16. Flavell, Richard A. |
  17. Kobayashi, Yasushi |
  18. Renné, Thomas |
  19. Gerloff, Christian |
  20. Huber, Samuel |
  21. Magnus, Tim |
  22. Gelderblom, Mathias |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-11-13
1000 Erschienen in
1000 Quellenangabe
  • 18(1):265
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12974-021-02316-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590298/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Lymphocytes have dichotomous functions in ischemic stroke. Regulatory T cells are protective, while IL-17A from innate lymphocytes promotes the infarct growth. With recent advances of T cell-subtype specific transgenic mouse models it now has become possible to study the complex interplay of T cell subpopulations in ischemic stroke.!##!Methods!#!In a murine model of experimental stroke we analyzed the effects of IL-10 on the functional outcome for up to 14 days post-ischemia and defined the source of IL-10 in ischemic brains based on immunohistochemistry, flow cytometry, and bone-marrow chimeric mice. We used neutralizing IL-17A antibodies, intrathecal IL-10 injections, and transgenic mouse models which harbor a deletion of the IL-10R on distinct T cell subpopulations to further explore the interplay between IL-10 and IL-17A pathways in the ischemic brain.!##!Results!#!We demonstrate that IL-10 deficient mice exhibit significantly increased infarct sizes on days 3 and 7 and enlarged brain atrophy and impaired neurological outcome on day 14 following tMCAO. In ischemic brains IL-10 producing immune cells included regulatory T cells, macrophages, and microglia. Neutralization of IL-17A following stroke reversed the worse outcome in IL-10 deficient mice and intracerebral treatment with recombinant IL-10 revealed that IL-10 controlled IL-17A positive lymphocytes in ischemic brains. Importantly, IL-10 acted differentially on αβ and γδ T cells. IL-17A producing CD4!##!Conclusions!#!Taken together, our data indicate a key function of IL-10 in restricting the detrimental IL-17A-signaling in stroke and further supports that IL-17A is a therapeutic opportunity for stroke treatment.
1000 Sacherschließung
lokal Mice, Inbred C57BL [MeSH]
lokal CD4-Positive T-Lymphocytes/drug effects [MeSH]
lokal Interleukin-17/antagonists
lokal Ischemic Stroke/drug therapy [MeSH]
lokal Interleukin-10/therapeutic use [MeSH]
lokal Mice, Transgenic [MeSH]
lokal Stroke
lokal Ischemia
lokal T cells
lokal Interleukin-10
lokal Interleukin-17
lokal Receptors, Interleukin-10/antagonists
lokal Inflammation
lokal Infarction, Middle Cerebral Artery/prevention
lokal Treatment Outcome [MeSH]
lokal Antibodies, Neutralizing/pharmacology [MeSH]
lokal T-Lymphocytes, Regulatory/immunology [MeSH]
lokal T-Lymphocytes, Regulatory/drug effects [MeSH]
lokal Animals [MeSH]
lokal Injections, Spinal [MeSH]
lokal Interleukin-10/administration
lokal Immunohistochemistry [MeSH]
lokal CD4-Positive T-Lymphocytes/immunology [MeSH]
lokal Mice [MeSH]
lokal Research
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/UGllcGtlLCBNYXJpdXM=|https://frl.publisso.de/adhoc/uri/Q2xhdXNlbiwgQmV0dGluYSBILg==|https://frl.publisso.de/adhoc/uri/THVkZXdpZywgUGV0ZXI=|https://frl.publisso.de/adhoc/uri/Vmllbmh1ZXMsIEpvbmFzIEgu|https://frl.publisso.de/adhoc/uri/QmVka2UsIFRhbmph|https://frl.publisso.de/adhoc/uri/SmF2aWRpLCBFaHNhbg==|https://frl.publisso.de/adhoc/uri/Umlzc2llaywgQmrDtnJu|https://frl.publisso.de/adhoc/uri/SmFuaywgTGFyaXNzYQ==|https://frl.publisso.de/adhoc/uri/QnJvY2ttYW5uLCBMZW9uaWU=|https://frl.publisso.de/adhoc/uri/U2FuZHJvY2ssIEluZ2E=|https://frl.publisso.de/adhoc/uri/RGVnZW5oYXJkdCwgS2Fyb2xpbmU=|https://frl.publisso.de/adhoc/uri/SmFuZGVyLCBBbGluYQ==|https://frl.publisso.de/adhoc/uri/Um90aCwgVmFuZXNzYQ==|https://frl.publisso.de/adhoc/uri/U2Now6RkbGljaCwgSW5lcyBTLg==|https://frl.publisso.de/adhoc/uri/UHJpbnosIEltbW8=|https://frl.publisso.de/adhoc/uri/RmxhdmVsbCwgUmljaGFyZCBBLg==|https://frl.publisso.de/adhoc/uri/S29iYXlhc2hpLCBZYXN1c2hp|https://frl.publisso.de/adhoc/uri/UmVubsOpLCBUaG9tYXM=|https://frl.publisso.de/adhoc/uri/R2VybG9mZiwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/SHViZXIsIFNhbXVlbA==|https://frl.publisso.de/adhoc/uri/TWFnbnVzLCBUaW0=|https://frl.publisso.de/adhoc/uri/R2VsZGVyYmxvbSwgTWF0aGlhcw==
1000 Hinweis
  • DeepGreen-ID: 50197396e2b44710bd4b1e2fd3163b45 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6465798.rdf
1000 Erstellt am 2023-11-16T16:35:14.745+0100
1000 Erstellt von 322
1000 beschreibt frl:6465798
1000 Zuletzt bearbeitet 2023-12-01T03:09:13.748+0100
1000 Objekt bearb. Fri Dec 01 03:09:13 CET 2023
1000 Vgl. frl:6465798
1000 Oai Id
  1. oai:frl.publisso.de:frl:6465798 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source